[Intra-arterial COMPA chemotherapy for invasive bladder cancer].


We presented 12 patients with invasive bladder cancer treated by the subselective intra-arterial COMPA chemotherapy. COMPA was administered up to an average of 3.3 courses (ranged from 2 to 6 courses) every 2 or 3 weeks, consisting of cisplatin: 15 mg/M2 on days 4 and 5; vincristine (oncovin): 0.6 mg/M2 on days 1 and 2; methotrexate: 5 mg/M2 on days 2 and 3… (More)


Cite this paper

@article{Tsujino1992IntraarterialCC, title={[Intra-arterial COMPA chemotherapy for invasive bladder cancer].}, author={Shiho Tsujino and T. Yamauchi and M Kokuho and Takashi Kobayashi and Yutaro Tachibana and Shinji Sawano and T. Kawai}, journal={Nihon Hinyokika Gakkai zasshi. The japanese journal of urology}, year={1992}, volume={83 10}, pages={1640-6} }